More on ABLD
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $30.62 |
|
|||
| Open | $30.80 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $30.90 | ||||
| Day Low | $30.74 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 8,484 | ||||
- ABL Diagnostics: Ordinary and Extraordinary General Meeting of September 17, 2026 – Arrangements for the Availability and Consultation of Preparatory Documents
- ABL Diagnostics: Information Relating to the Total Number of Voting Rights and the Number of Shares Constituting the Share Capital
- ABL Diagnostics - Proposed Transfer of the Listing of Its Securities From the Regulated Market of Euronext Paris to Euronext Growth Paris
- ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL
- ABL Diagnostics Announces Amendment to the Equity Line and Share Loan Agreement Between Its Main Shareholder ABL SA (Luxembourg) and Alumni Capital
- ABL Diagnostics to acquire Texcell assets via French court ruling
- ABL Diagnostics Selected by the Évry Commercial Court to Acquire TEXCELL’s Operations
- ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL
- ABL Diagnostics Informed that its Reference Shareholder ABL Has Crossed Below the 95% Threshold
- ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL
